Elanco Receives the US FTC's Approval for Acquisition of Bayer Animal Health
Shots:
- Elanco has received the US FTC’s approval for its acquisition of Bayer Animal Health- representing the final antitrust clearance needed to complete the transaction- which continues track for closing at the beginning of August
- The FTC’s approval follows divestiture of global rights for Osurnia to treat otitis externa in dogs- US rights for Capstar that kills fleas in dogs and cats- and StandGuard that treat horn fly and lice control in beef cattle
- In addition to FTC approval- Elanco has received antitrust clearance for the transaction from the EC- Australia- Brazil- Canada- China- Colombia- New Zealand- South Africa- Turkey- Ukraine- and Vietnam
Ref: Elanco | Image: Seeking alpha
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com